Taylor Sandison

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

George R. Thompson, Àlex Soriano, Oliver A. Cornely et al. · The Lancet · 2022 · 150 citations · Full text

Translational Medicine, Antifungal Agent, Antifungal Agents +6

Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults

Taylor Sandison, Voon Ong, Jonathan Lee et al. · Antimicrobial Agents and Chemotherapy · 2016 · 149 citations · Full text

Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort

Steven A. Pergam, Chia C. Wang, Carolyn Gardella et al. · American Journal of Obstetrics and Gynecology · 2008 · 146 citations · Full text

Hepatitis C, Maternal Complication, Clinical Epidemiology +11

Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial

George R. Thompson, Àlex Soriano, Athanasios Skoutelis et al. · Clinical Infectious Diseases · 2020 · 144 citations · Full text

Artemether‐Lumefantrine versus Dihydroartemisinin‐Piperaquine for Falciparum Malaria: A Longitudinal, Randomized Trial in Young Ugandan Children

Emmanuel Arinaitwe, Taylor Sandison, Humphrey Wanzira et al. · Clinical Infectious Diseases · 2009 · 123 citations